Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance

[1]  Mohd Hamid,et al.  Breast Cancer Risk Assessment Tool , 2014 .

[2]  Konstantin Strauch,et al.  Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance , 2012, Breast Cancer Research.

[3]  R. Santella,et al.  Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. , 2012, Carcinogenesis.

[4]  R. Santella,et al.  Genomic Methylation Changes Over Time in Peripheral Blood Mononuclear Cell DNA: Differences by Assay Type and Baseline Values , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[5]  Ammarin Thakkinstian,et al.  Risk prediction models of breast cancer: a systematic review of model performances , 2012, Breast Cancer Research and Treatment.

[6]  M. Pike,et al.  Invasive breast cancer incidence trends by detailed race/ethnicity and age , 2012, International journal of cancer.

[7]  Mitchell H Gail,et al.  Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. , 2011, Journal of the National Cancer Institute.

[8]  V Shane Pankratz,et al.  Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Evans,et al.  Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.

[10]  D. Saslow,et al.  Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening , 2010, CA: a cancer journal for clinicians.

[11]  Cecelia Bellcross,et al.  Approaches to applying breast cancer risk prediction models in clinical practice , 2009 .

[12]  A. Whittemore,et al.  BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research , 2009, Breast Cancer Research and Treatment.

[13]  Christi J. van Asperen,et al.  Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? , 2009, Breast Cancer Research and Treatment.

[14]  R. Santella,et al.  Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. , 2009, Cancer research.

[15]  O. Olopade,et al.  Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Vierkant,et al.  Assessment of the accuracy of the Gail model in women with atypical hyperplasia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Melissa Bondy,et al.  Projecting individualized absolute invasive breast cancer risk in African American women. , 2007, Journal of the National Cancer Institute.

[18]  R. Santella,et al.  Short telomere length and breast cancer risk: a study in sister sets. , 2007, Cancer research.

[19]  L. Ford,et al.  Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.

[20]  Margaret Sullivan Pepe,et al.  Standardizing Diagnostic Markers to Evaluate and Compare Their Performance , 2005, Epidemiology.

[21]  Mitchell H Gail,et al.  On criteria for evaluating models of absolute risk. , 2005, Biostatistics.

[22]  D. Kennedy,et al.  DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. , 2005, Journal of the National Cancer Institute.

[23]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.

[24]  Norman Boyd,et al.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.

[25]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[26]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[27]  C. Broeckhoven,et al.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.

[28]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .

[29]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[30]  J Benichou,et al.  Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.

[31]  D Spiegelman,et al.  Validation of the Gail et al. model for predicting individual breast cancer risk. , 1994, Journal of the National Cancer Institute.

[32]  E. Lustbader,et al.  Validation of a breast cancer risk assessment model in women with a positive family history. , 1994, Journal of the National Cancer Institute.

[33]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[34]  N. Risch,et al.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer , 1993, Breast Cancer Research and Treatment.

[35]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[36]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[37]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[38]  A. Leitch,et al.  Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic , 2002, The breast journal.